{"id":"https://openalex.org/W4391396752","doi":"https://doi.org/10.3389/fonc.2024.1296576","title":"RETRACTED: PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults","display_name":"RETRACTED: PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults","publication_year":2024,"publication_date":"2024-01-30","ids":{"openalex":"https://openalex.org/W4391396752","doi":"https://doi.org/10.3389/fonc.2024.1296576","pmid":"https://pubmed.ncbi.nlm.nih.gov/38357205","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10864630"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2024.1296576","doi":"https://doi.org/10.3389/fonc.2024.1296576","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2024.1296576","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fonc.2024.1296576","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016036366","display_name":"Nicola Fenwick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135017","display_name":"Cancer Research UK Clinical Trials Unit","ror":"https://ror.org/03qxptw71","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I4210135017","https://openalex.org/I79619799"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicola Fenwick","raw_affiliation_strings":["Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I4210135017","https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072490471","display_name":"Rebekah Weston","orcid":"https://orcid.org/0000-0002-7884-1884","observed_orcids":["https://orcid.org/0000-0002-7884-1884"]},"institutions":[{"id":"https://openalex.org/I4210135017","display_name":"Cancer Research UK Clinical Trials Unit","ror":"https://ror.org/03qxptw71","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I4210135017","https://openalex.org/I79619799"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rebekah Weston","raw_affiliation_strings":["Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I4210135017","https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018693666","display_name":"Keith Wheatley","orcid":"https://orcid.org/0000-0003-0792-580X","observed_orcids":["https://orcid.org/0000-0003-0792-580X"]},"institutions":[{"id":"https://openalex.org/I4210135017","display_name":"Cancer Research UK Clinical Trials Unit","ror":"https://ror.org/03qxptw71","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I4210135017","https://openalex.org/I79619799"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Keith Wheatley","raw_affiliation_strings":["Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I4210135017","https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jodie Hodgson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135017","display_name":"Cancer Research UK Clinical Trials Unit","ror":"https://ror.org/03qxptw71","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I4210135017","https://openalex.org/I79619799"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jodie Hodgson","raw_affiliation_strings":["Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I4210135017","https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085820190","display_name":"Lynley V. Marshall","orcid":"https://orcid.org/0000-0002-6537-2118","observed_orcids":["https://orcid.org/0000-0002-6537-2118"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lynley Marshall","raw_affiliation_strings":["The Royal Marsden, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden, Sutton, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031453300","display_name":"Martin Elliott","orcid":"https://orcid.org/0000-0002-8062-6913","observed_orcids":["https://orcid.org/0000-0002-8062-6913"]},"institutions":[{"id":"https://openalex.org/I2801331674","display_name":"St James's University Hospital","ror":"https://ror.org/013s89d74","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153","https://openalex.org/I2801331674"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin Elliott","raw_affiliation_strings":["Leeds Teaching Hospital, St James University Hospital, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds Teaching Hospital, St James University Hospital, Leeds, United Kingdom","institution_ids":["https://openalex.org/I2801331674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036070143","display_name":"Guy Makin","orcid":"https://orcid.org/0000-0003-3513-3957","observed_orcids":["https://orcid.org/0000-0003-3513-3957"]},"institutions":[{"id":"https://openalex.org/I4210160221","display_name":"Royal Manchester Children's Hospital","ror":"https://ror.org/052vjje65","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210160221"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Guy Makin","raw_affiliation_strings":["Royal Manchester Children's Hospital, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Manchester Children's Hospital, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210160221"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023844220","display_name":"Antony Ng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801868026","display_name":"Bristol Royal Hospital for Children","ror":"https://ror.org/01qgecw57","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801868026","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Antony Ng","raw_affiliation_strings":["Bristol Royal Hospital for Children, Bristol, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Royal Hospital for Children, Bristol, United Kingdom","institution_ids":["https://openalex.org/I2801868026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064402714","display_name":"Bernadette M. D. Brennan","orcid":"https://orcid.org/0000-0003-1614-0289","observed_orcids":["https://orcid.org/0000-0003-1614-0289","https://orcid.org/0009-0003-2805-8079"]},"institutions":[{"id":"https://openalex.org/I4210160221","display_name":"Royal Manchester Children's Hospital","ror":"https://ror.org/052vjje65","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210160221"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bernadette Brennan","raw_affiliation_strings":["Royal Manchester Children's Hospital, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Manchester Children's Hospital, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210160221"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108457620","display_name":"Stephen P. Lowis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801868026","display_name":"Bristol Royal Hospital for Children","ror":"https://ror.org/01qgecw57","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801868026","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen Lowis","raw_affiliation_strings":["Bristol Royal Hospital for Children, Bristol, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Royal Hospital for Children, Bristol, United Kingdom","institution_ids":["https://openalex.org/I2801868026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066990891","display_name":"Jenny K. Adamski","orcid":"https://orcid.org/0000-0003-0999-6169","observed_orcids":["https://orcid.org/0000-0003-0999-6169"]},"institutions":[{"id":"https://openalex.org/I4210100347","display_name":"Birmingham Children's Hospital","ror":"https://ror.org/017k80q27","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210100347","https://openalex.org/I4210155225"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jenny Adamski","raw_affiliation_strings":["Birmingham Children's Hospital, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Birmingham Children's Hospital, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I4210100347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060875428","display_name":"John\u2010Paul Kilday","orcid":"https://orcid.org/0000-0002-0539-215X","observed_orcids":["https://orcid.org/0000-0002-0539-215X"]},"institutions":[{"id":"https://openalex.org/I4210160221","display_name":"Royal Manchester Children's Hospital","ror":"https://ror.org/052vjje65","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210160221"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Paul Kilday","raw_affiliation_strings":["Royal Manchester Children's Hospital, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Manchester Children's Hospital, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210160221"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009313102","display_name":"Rachel Cox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801868026","display_name":"Bristol Royal Hospital for Children","ror":"https://ror.org/01qgecw57","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801868026","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rachel Cox","raw_affiliation_strings":["Bristol Royal Hospital for Children, Bristol, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Royal Hospital for Children, Bristol, United Kingdom","institution_ids":["https://openalex.org/I2801868026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036590766","display_name":"Mike Gattens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156194","display_name":"Addenbrooke's Hospital","ror":"https://ror.org/055vbxf86","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933","https://openalex.org/I4210156194"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mike Gattens","raw_affiliation_strings":["Addenbrookes Hospital, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Addenbrookes Hospital, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210156194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035808651","display_name":"Andrew S. Moore","orcid":"https://orcid.org/0000-0001-8062-1779","observed_orcids":["https://orcid.org/0000-0001-8062-1779","https://orcid.org/0009-0008-7037-6640"]},"institutions":[{"id":"https://openalex.org/I4210167058","display_name":"Children's Health Queensland Hospital and Health Service","ror":"https://ror.org/02t3p7e85","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2801244131","https://openalex.org/I4210167058"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew Moore","raw_affiliation_strings":["Queensland Children's Hospital, Brisbane, QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queensland Children's Hospital, Brisbane, QLD, Australia","institution_ids":["https://openalex.org/I4210167058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022402043","display_name":"Toby N. Trahair","orcid":"https://orcid.org/0000-0002-3295-228X","observed_orcids":["https://orcid.org/0000-0002-3295-228X"]},"institutions":[{"id":"https://openalex.org/I4210125633","display_name":"Sydney Children's Hospital","ror":"https://ror.org/02tj04e91","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210125633","https://openalex.org/I4210149013"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Toby Trahair","raw_affiliation_strings":["Sydney Children's Hospital, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sydney Children's Hospital, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I4210125633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018901372","display_name":"Milind Ronghe","orcid":"https://orcid.org/0000-0002-1865-9335","observed_orcids":["https://orcid.org/0000-0002-1865-9335"]},"institutions":[{"id":"https://openalex.org/I2800398797","display_name":"Royal Hospital for Children","ror":"https://ror.org/01cb0kd74","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399","https://openalex.org/I2800398797"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Milind Ronghe","raw_affiliation_strings":["Royal Hospital for Children, Glasgow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Hospital for Children, Glasgow, United Kingdom","institution_ids":["https://openalex.org/I2800398797"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053813271","display_name":"Martin Campbell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1321649718","display_name":"Royal Children's Hospital","ror":"https://ror.org/02rktxt32","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1321649718"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Martin Campbell","raw_affiliation_strings":["Royal Children's Hospital, Melbourne, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Children's Hospital, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I1321649718"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Helen Campbell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160221","display_name":"Royal Manchester Children's Hospital","ror":"https://ror.org/052vjje65","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210160221"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Helen Campbell","raw_affiliation_strings":["Royal Manchester Children's Hospital, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Manchester Children's Hospital, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210160221"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Molly W. Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1321649718","display_name":"Royal Children's Hospital","ror":"https://ror.org/02rktxt32","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1321649718"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Molly W. Williams","raw_affiliation_strings":["Royal Children's Hospital, Melbourne, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Children's Hospital, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I1321649718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078529390","display_name":"Maria L. Kirby","orcid":"https://orcid.org/0000-0002-8786-3532","observed_orcids":["https://orcid.org/0000-0002-8786-3532"]},"institutions":[{"id":"https://openalex.org/I2801308011","display_name":"Women's and Children's Hospital","ror":"https://ror.org/03kwrfk72","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801308011"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Maria Kirby","raw_affiliation_strings":["Michael Rice Cancer Centre, Women's and Children's Hospital, North Adelaide, SA, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Michael Rice Cancer Centre, Women's and Children's Hospital, North Adelaide, SA, Australia","institution_ids":["https://openalex.org/I2801308011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060294217","display_name":"Natasha K. A. van Eijkelenburg","orcid":"https://orcid.org/0000-0002-0526-3737","observed_orcids":["https://orcid.org/0000-0002-0526-3737"]},"institutions":[{"id":"https://openalex.org/I4210127118","display_name":"Princess M\u00e1xima Center","ror":"https://ror.org/02aj7yc53","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210127118"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Natasha Van Eijkelenburg","raw_affiliation_strings":["Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands","institution_ids":["https://openalex.org/I4210127118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072058444","display_name":"Jennifer Keely","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135017","display_name":"Cancer Research UK Clinical Trials Unit","ror":"https://ror.org/03qxptw71","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I4210135017","https://openalex.org/I79619799"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jennifer Keely","raw_affiliation_strings":["Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I4210135017","https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040294275","display_name":"Ugo Scarpa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ugo Scarpa","raw_affiliation_strings":["Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070757024","display_name":"Victoria Stavrou","orcid":"https://orcid.org/0009-0009-3245-4967","observed_orcids":["https://orcid.org/0009-0009-3245-4967"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Victoria Stavrou","raw_affiliation_strings":["Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060431616","display_name":"Livingstone Fultang","orcid":"https://orcid.org/0000-0002-8215-6660","observed_orcids":["https://orcid.org/0000-0002-8215-6660"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Livingstone Fultang","raw_affiliation_strings":["Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112785273","display_name":"Sarah Booth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Booth","raw_affiliation_strings":["Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082459275","display_name":"Paul Cheng","orcid":"https://orcid.org/0000-0003-0351-8991","observed_orcids":["https://orcid.org/0000-0003-0351-8991"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Cheng","raw_affiliation_strings":["Bio-Cancer Treatment International, Hong Kong Science Park, Hong Kong, Hong Kong SAR, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bio-Cancer Treatment International, Hong Kong Science Park, Hong Kong, Hong Kong SAR, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967082","display_name":"Carmela De Santo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Carmela De Santo","raw_affiliation_strings":["Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052506270","display_name":"Francis Mussai","orcid":"https://orcid.org/0000-0003-3342-0047","observed_orcids":["https://orcid.org/0000-0003-3342-0047"]},"institutions":[{"id":"https://openalex.org/I4210100347","display_name":"Birmingham Children's Hospital","ror":"https://ror.org/017k80q27","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210100347","https://openalex.org/I4210155225"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Francis Mussai","raw_affiliation_strings":["Birmingham Children's Hospital, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Birmingham Children's Hospital, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I4210100347"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5052506270"],"corresponding_institution_ids":["https://openalex.org/I4210100347"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":2.7919,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.91243159,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"14","issue":null,"first_page":"1296576","last_page":"1296576"},"is_retracted":true,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.01850000023841858,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/arginine-deprivation","display_name":"arginine deprivation","score":0.7559999823570251},{"id":"https://openalex.org/keywords/arginine-metabolism","display_name":"arginine metabolism","score":0.7940000295639038},{"id":"https://openalex.org/keywords/children-and-young-adults","display_name":"children and young adults","score":0.8790000081062317},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.746999979019165},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9229999780654907},{"id":"https://openalex.org/keywords/central-nervous-system-tumors","display_name":"central nervous system tumors","score":0.9169999957084656},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.7760000228881836},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6110000014305115},{"id":"https://openalex.org/keywords/disease-stability","display_name":"disease stability","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8274791240692139},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.682086706161499},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5646185278892517},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5072686076164246},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4944929778575897},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4607388377189636},{"id":"https://openalex.org/C164007495","wikidata":"https://www.wikidata.org/wiki/Q24721374","display_name":"Arginase","level":4,"score":0.45702099800109863},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.43010738492012024},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4237535297870636},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4176065921783447},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.411310613155365},{"id":"https://openalex.org/C2777468819","wikidata":"https://www.wikidata.org/wiki/Q173670","display_name":"Arginine","level":3,"score":0.3794538378715515},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.33477693796157837},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3389/fonc.2024.1296576","doi":"https://doi.org/10.3389/fonc.2024.1296576","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2024.1296576","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10864630","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10864630","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10864630/pdf/fonc-14-1296576.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:38357205","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38357205","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/1fc33742-93f1-44a1-8042-21acd741ae77","doi":null,"is_oa":true,"landing_page_url":"https://research.manchester.ac.uk/en/publications/1fc33742-93f1-44a1-8042-21acd741ae77","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire/d5abb5f4-1d2a-4d60-965b-58edcb56fd77","doi":null,"is_oa":true,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/d5abb5f4-1d2a-4d60-965b-58edcb56fd77","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:4902b15b11094343be86c12a848d2cb8","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4902b15b11094343be86c12a848d2cb8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 14 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2024.1296576","doi":"https://doi.org/10.3389/fonc.2024.1296576","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2024.1296576","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G7179533931","display_name":null,"funder_award_id":"28028","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320310702","display_name":"National Cancer Research Institute","ror":"https://ror.org/02mp0vf47"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4391396752.pdf","grobid_xml":"https://content.openalex.org/works/W4391396752.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1911361012","https://openalex.org/W2005944449","https://openalex.org/W2019607817","https://openalex.org/W2081060988","https://openalex.org/W2087285715","https://openalex.org/W2147083172","https://openalex.org/W2154648586","https://openalex.org/W2280328154","https://openalex.org/W2555868191","https://openalex.org/W2611071372","https://openalex.org/W2724098825","https://openalex.org/W2768987366","https://openalex.org/W3037982221","https://openalex.org/W3153390253","https://openalex.org/W3185514839","https://openalex.org/W3193141331","https://openalex.org/W3211101762","https://openalex.org/W4309409772","https://openalex.org/W4309643050"],"related_works":["https://openalex.org/W3185514839","https://openalex.org/W2555893049","https://openalex.org/W2768987366","https://openalex.org/W2979546414","https://openalex.org/W2267303727","https://openalex.org/W2725201658","https://openalex.org/W3153390253","https://openalex.org/W4243916296","https://openalex.org/W2785507956","https://openalex.org/W2564795524"],"abstract_inverted_index":{"Background:":[0],"The":[1,74,116,179,254],"survival":[2],"for":[3],"many":[4],"children":[5,44,175,251,259],"with":[6,45,144,161,252,260],"relapsed/refractory":[7,46,234,261],"cancers":[8,146,262],"remains":[9],"poor":[10],"despite":[11],"advances":[12],"in":[13,21,34,43,108,135,196,218,250,258,276],"therapies.":[14],"Arginine":[15,241],"metabolism":[16],"plays":[17],"a":[18,25,38,55,79,211,230,244],"key":[19],"role":[20],"the":[22,32,91,95,109,125,131,136,184,187,222],"pathophysiology":[23],"of":[24,27,37,98,114,128,142,154,183,192,200,232,256],"number":[26,231],"pediatric":[28,132,145],"cancers.":[29,51],"We":[30],"report":[31],"first":[33],"child":[35],"study":[36],"recombinant":[39],"human":[40],"arginase,":[41],"BCT-100,":[42],"hematological,":[47],"solid":[48],"or":[49,170,214],"CNS":[50],"Procedure:":[52],"PARC":[53],"was":[54,65,87,120,156,203],"single":[56],"arm,":[57],"Phase":[58,75,117,137,180,189],"I/II,":[59],"international,":[60],"open":[61],"label":[62],"study.":[63],"BCT-100":[64,129,202,257],"given":[66],"intravenously":[67,267],"over":[68],"one":[69],"hour":[70],"at":[71,130,158,265],"weekly":[72,195,268],"intervals.":[73],"I":[76,138,181],"section":[77,119],"utilized":[78],"modified":[80],"3":[81,83],"+":[82],"design":[84],"where":[85],"escalation/de-escalation":[86],"based":[88],"on":[89],"both":[90],"safety":[92],"profile":[93],"and":[94,247,269,289],"complete":[96],"depletion":[97,242],"arginine":[99,103,107],"(defined":[100],"as":[101,210],"adequate":[102],"depletion;":[104],"AAD":[105],"<8\u03bcM":[106],"blood":[110],"after":[111],"4":[112,148],"doses":[113],"BCT-100).":[115],"II":[118,190],"designed":[121],"to":[122,164,272,279],"further":[123],"evaluate":[124],"clinical":[126],"activity":[127],"RP2D":[133,255],"determined":[134],"section,":[139],"by":[140],"recruitment":[141],"patients":[143,162,235],"into":[147],"individual":[149],"groups.":[150],"A":[151],"primary":[152,226],"evaluation":[153,227],"response":[155],"conducted":[157],"eight":[159],"weeks":[160],"continuing":[163],"receive":[165],"treatment":[166],"until":[167],"disease":[168,274],"progression":[169],"unacceptable":[171],"toxicity.":[172],"Results:":[173],"49":[174],"were":[176,216],"recruited":[177],"globally.":[178],"cohort":[182,220],"trial":[185,283],"established":[186,264],"Recommended":[188],"Dose":[191],"1600U/kg":[193,266],"iv":[194],"children,":[197],"matching":[198],"that":[199],"adults.":[201],"very":[204],"well":[205],"tolerated.":[206],"No":[207],"responses":[208],"defined":[209,223],"CR,":[212],"CRi":[213],"PR":[215],"seen":[217],"any":[219],"within":[221],"8":[224],"week":[225],"period.":[228],"However":[229],"these":[233],"experienced":[236],"prolonged":[237],"radiological":[238],"SD.":[239],"Conclusion:":[240],"is":[243,263],"clinically":[245],"safe":[246],"achievable":[248],"strategy":[249],"cancer.":[253],"can":[270],"lead":[271],"sustained":[273],"stability":[275],"this":[277],"hard":[278],"treat":[280],"population.":[281],"Clinical":[282],"registration:":[284],"EudraCT,":[285],"2017-002762-44;":[286],"ISRCTN,":[287],"21727048;":[288],"ClinicalTrials.gov,":[290],"NCT03455140.":[291]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-02-01T00:00:00"}